Intangible assets primarily consist of lease-up intangibles and above market lease intangibles. The following table summarizes the Company’s intangible lease assets (dollars in thousands):


Intangible lease assets	June 30, 2024		December 31, 2023
Gross intangible lease assets(1)	$	1,611,677	$	739,228
Accumulated depreciation and amortization(2)	(535,590)		(425,072)
Intangible assets, net	$	1,076,087	$	314,156

Weighted average remaining amortization period in years	5		5

(1)As of June 30, 2024 and December 31, 2023, includes $1.56 billion and $725 million, respectively, of gross lease-up intangibles and $53 million and $14 million, respectively, of gross above market lease intangibles.

(2)As of June 30, 2024 and December 31, 2023, includes $525 million and $418 million, respectively, of accumulated depreciation and amortization on lease-up intangibles and $11 million and $7 million, respectively, of accumulated depreciation and amortization on above market lease intangibles.

Intangible liabilities consist of below market lease intangibles. The following table summarizes the Company’s intangible lease liabilities (dollars in thousands):


Intangible lease liabilities	June 30, 2024		December 31, 2023
Gross intangible lease liabilities	$	374,084	$	228,105
Accumulated depreciation and amortization	(146,714)		(100,725)
Intangible liabilities, net	$	227,370	$	127,380

Weighted average remaining amortization period in years	9		7

On the Closing Date of the Merger, the Company acquired intangible assets of $891 million, inclusive of $852 million of lease-up intangibles and $39 million of above market lease intangibles, and intangible liabilities of $150 million (see Note 3). The intangible assets and liabilities acquired had a weighted average amortization period at acquisition of 6 years and 9 years, respectively.

During the year ended December 31, 2023, in conjunction with the Company’s acquisition of real estate, the Company acquired $0.5 million of intangible assets with a weighted average amortization period at acquisition of 5 years.

On the Closing Date of the Merger, the Company recognized goodwill of $47 million, which was allocated to the Company’s outpatient medical segment (see Note 3). Goodwill is included in other assets, net on the Consolidated Balance Sheets. At June 30, 2024 and December 31, 2023, goodwill was allocated to the Company’s segment assets as follows (in thousands):


Segment	June 30, 2024		December 31, 2023
Outpatient medical	$	61,314	$	14,178
CCRC	1,998		1,998
Other non-reportable	1,851		1,851

	$	65,163	$	18,027